This inventor holds 2 USPTO granted patents. Top assignee: Rhone-Poulenc Rorer S.a.. Active years: 1996-1997.
Location History:
- Chevilly-Larue, FR (1996)
- Villemoisson-su-Orge, FR (1997)
Company Filing History:
Years Active: 1996-1997
Title: Marie-Therese David-Comte: Innovator in Pharmaceutical Chemistry
Introduction
Marie-Therese David-Comte is a notable inventor based in Chevilly-Larue, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. With a total of 2 patents, her work has garnered attention for its potential impact on health and medicine.
Latest Patents
One of her latest patents is a method for preparing N-methyl 2-(3-pyridyl). This invention relates to a process for the preparation of (1R,2R)-N-methyl-2-(3-pyridyl)tetrahydrothiopyran-2-carbothioamide 1-oxide, which is particularly useful as an antihypertensive and as a cardioprotective agent. Another significant patent involves a novel 2-amino naphthyridine derivative, its preparation, and its use. This invention focuses on 2-aminonaphthyridine compounds that are useful in preparing a 2-isoindolinyl naphthyridine compound, exhibiting remarkable anxiolytic, hypnotic, anticonvulsant, antiepileptic, and muscle-relaxant properties.
Career Highlights
Marie-Therese David-Comte has worked with Rhone-Poulenc Rorer S.A., a company known for its commitment to innovation in pharmaceuticals. Her research and inventions have contributed to advancements in drug development and therapeutic solutions.
Collaborations
Throughout her career, she has collaborated with various professionals, including her coworker Gerard Roussel, to enhance the scope and impact of her research.
Conclusion
Marie-Therese David-Comte's contributions to pharmaceutical chemistry through her innovative patents highlight her role as a leading inventor in her field. Her work continues to influence the development of important therapeutic agents.